Skip to main content
Log in

Therapie idiopathischer Kopfschmerzen im Kindes- und Jugendalter

Revidierte Empfehlungen der Gesellschaft für Neuropädiatrie (GNP) und der Deutschen Migräne- und Kopfschmerzgesellschaft (DMKG)

Treatment of idiopathic headache in childhood and adolescence

Revised recommendations of the Society for Neuropediatrics and the German Migraine and Headache Society

  • Konsensuspapiere
  • Published:
Monatsschrift Kinderheilkunde Aims and scope Submit manuscript

Zusammenfassung

Nach den Richtlinien der „evidence-based medicine“ wurden die spezifischen kontrollierten Studien für die Behandlung von idiopathischen Kopfschmerzen im Kindes- und Jugendalter analysiert und in Therapieempfehlungen zusammengefasst. Mit der höchsten Evidenz wird für die Behandlung akuter Migräneattacken oder von Kopfschmerzen vom Spannungstyp Ibuprofen (10 mg pro kg Körpergewicht) empfohlen. Als Mittel der zweiten Wahl für alle Altersstufen gilt Paracetamol (15 mg/kg KG). Ab dem 12. Lebensjahr ist für Migräneattacken auch Sumatriptan Nasenspray (10–20 mg) Mittel der zweiten Wahl (im Einzelfall kann es auch bei jüngeren Kindern eingesetzt werden). Bei Versagen der Akutmedikamente der ersten und zweiten Wahl kann auf Substanzen der dritten Wahl wie Zolmitriptan 2,5 mg als Schmelztablette, Zolmitriptan 5 mg als Nasenspray, Rizatriptan 5–10 mg, Almotriptan 12,5 und Dihydroergotamin 20–40 µg/kg KG ausgewichen werden. Für die medikamentöse Prophylaxe der Migräne werden Magnesium, Betablocker (Propranolol oder Metoprolol) und Flunarizin empfohlen. Flunarizin ist auch prophylaktisches Mittel der ersten Wahl bei migräneähnlichen Syndromen. Für andere Kopfschmerzarten liegen keine kontrollierten Studien für das Kindesalter vor. In der nichtmedikamentösen Prophylaxe von Kopfschmerzen im Kindesalter werden mit höchster Evidenz Entspannungsverfahren (progressive Muskelrelaxation), Biofeedbackverfahren und kindgerechte kognitiv-verhaltensorientierte Therapieprogramme empfohlen.

Abstract

According to the principles of evidence-based medicine, controlled studies on the treatment of idiopathic headache in childhood and adolescence were analysed and compiled into treatment recommendations. For acute treatment of migraine attacks or tension-type headache, ibuprofen (10 mg/kg body weight) is most highly recommended. Drugs of second choice are acetaminophen (15 mg/kg body weight) for all ages and for migraine attacks only, intranasal sumatriptan (10–20 mg) for the age of 12  years and older, in isolated cases also below 12 years of age. If the first or second choice acute drugs are not effective alternative drugs of third choice are zolmitriptan 2.5 mg as melting tablet, intranasal zolmitriptan 5 mg, rizatriptan 5–10 mg, almotriptan 12.5 and dihydroergotamine 20–40 µg/kg body weight. For the prophylaxis of migraine, magnesium, betablockers (propranolol and metoprolol) and flunarizine are recommended. Flunarizine is also the drug of first choice for the prophylactic treatment of migraine-related disorders. No controlled studies are available on the treatment of further headache types in childhood. First line methods recommended for the non-drug prophylactic treatment of headache in childhood are progressive relaxation therapy, biofeedback procedures and specific cognitive-behavioral therapeutic schedules.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1

Literatur

  1. Abu-Arefeh I, Russell G (1994) Prevalence of headache and migraine in schoolchildren. Br Med J 309:765–769

    CAS  Google Scholar 

  2. Abu-Arafeh I, Russell G (1995) Cyclical vomiting syndrome in children: a population-based study. J Pediatr Gastroenterol Nutr 21:454–458

    PubMed  CAS  Google Scholar 

  3. Ahonen K, Hämäläinen ML, Rantala H, Hoppu K (2004) Nasal sumatriptan is effective in the treatment of migraine attacks in children. Neurology 62:883–887

    PubMed  CAS  Google Scholar 

  4. Ahonen K, Hämäläinen ML, Eerola M, Hoppu K (2006) A randomized trial of rizatriptan in migraine attacks in children. Neurology 67:1135–1140

    PubMed  CAS  Google Scholar 

  5. Alhashimi D, Alhashimi H, Fedorowicz Z (2006) Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescents. Cochrane Database Syst Rev 3:CD005506

    PubMed  CAS  Google Scholar 

  6. Allmendinger A, Ebinger F (2007) Diagnostik bei Kopfschmerzen im Kindesalter. Kinder Jugendarzt 38:373–379

    Google Scholar 

  7. Ambrosini PJ (2000) A review of pharmacotherapy of major depression in children and adolescents. Psychiatr Serv 51:627–633

    PubMed  CAS  Google Scholar 

  8. Amdorfer R, Allen K (2001) Extending the efficacy of a thermal biofeedback treatment package to the management of tension-type headache in children. Headache 41:183–192

    Google Scholar 

  9. Andersen JM, Sugerman KS, Lockhart JR, Weinberg WA (1997) Effective prophylactic therapy for cyclic vomiting syndrome in children using amitriptyline or cyproheptadine. Pediatrics 100:977–981

    PubMed  CAS  Google Scholar 

  10. Andrasik F, Grazzi L, Usai S, Bussone G (2007) Pharmacological treatment compared to behavioural treatment for juvenile tension-type headache: results at two-year follow-up. Neurol Sci 28 (Suppl 2):235–238

    Google Scholar 

  11. Anttila P (2006) Tension-type headache in childhood and adolescence. Lancet Neurol 5:268–274

    PubMed  Google Scholar 

  12. Anttila P, Metsähonkala L, Sillanpää M (2006) Long-term trends in the incidence of headache in Finnish schoolchildren. Pediatrics 117:1197–1201

    Google Scholar 

  13. Antonaci F, Sjaastad O (1989) Chronic paroxysmal hemicrania (CPH): a review of clinical manifestations. Headache 29:648–656

    PubMed  CAS  Google Scholar 

  14. Antonarakis ES, Hain RD (2004) Nausea and vomiting associated with cancer chemotherapy: drug management in theory and in practice. Arch Dis Child 89:877–880

    PubMed  CAS  Google Scholar 

  15. Apostol G, Cady RK, Laforet GA et al (2008) Divalproex extended-release in adolescent migraine prophylaxis: Results of a randomized, double-blind, placebo-controlled study. Headache 48:1012–1025

    PubMed  Google Scholar 

  16. Arruda MA, Bordini CA, Ciciarelli MC, Speciali JG (2004) Decreasing the minimal duration of the attack to 1 hour: is this sufficient to increase the sensitivity of the ICHD-II diagnostic criteria for migraine in childhood? J Headache Pain 5:131–136

    Google Scholar 

  17. Ashrafi MR, Shabanian R, Zamani GR, Mahfelati F (2005) Sodium valproate versus propranolol in pediatric migraine prophylaxis. Eur J Paediatr Neurol 9:333–338

    PubMed  CAS  Google Scholar 

  18. Balottin U, Termine C (2007) Recommendations for the management of migraine in paediatric patients. Exp Op Pharmacother 8:731–744

    CAS  Google Scholar 

  19. Barea LM, Tannhauser M, Rotta NT (1996) An epidemiologic study on headache among children and adolescents of southern Brazil. Cephalalgia 16:545–549

    PubMed  CAS  Google Scholar 

  20. Battistella PA, Ruffilli R, Moro R et al (1990) A placebo-controlled crossover trial of nimodipine in pediatric migraine. Headache 30: 264–268

    PubMed  CAS  Google Scholar 

  21. Battistella PA, Ruffilli R, Cernetti R et al (1993) A placebo-controlled crossover trial using trazodone in pediatric migraine. Headache 33:36–39

    PubMed  CAS  Google Scholar 

  22. Baumann RJ (2002) Behavioral treatment of migraine in children and adolescents. Pediatr Drugs 4:555–561

    Google Scholar 

  23. Benson JM, Zorn SL, Book LS (1995) Sumatriptan in the treatment of cyclic vomiting. Ann Pharmacother 29:997–999

    PubMed  CAS  Google Scholar 

  24. Bigal ME, Lipton RB, Tepper SJ et al (2004) Primary chronic daily headache and its subtypes in adolescents and adults. Neurology 63:843–847

    PubMed  CAS  Google Scholar 

  25. Bille B (1981) Migraine in childhood and its prognosis. Cephalalgia 1:71–75

    PubMed  CAS  Google Scholar 

  26. Bille B (1997) A 40-year follow-up of school children with migraine. Cephalalgia 17:488–4491

    PubMed  CAS  Google Scholar 

  27. Blättler T, Capone Mori A, Boltshauser E, Bassetti C (2006) Symptomatic SUNCT in an eleven-year-old girl. Neurology 60:2012–2013

    Google Scholar 

  28. Boccia G, Del Giudice E, Crisanti AF et al (2006) Functional gastrointestinal disorders in migrainous children: efficacy of flunarizine. Cephalalgia 26:1214–1219

    PubMed  CAS  Google Scholar 

  29. Bolton CM, Myles PS, Nolan T, Sterne JA (2006) Prophylaxis of postoperative vomiting in children undergoing tonsillectomy: a systematic review and meta-analysis. Br J Anaesth 97:593–604

    PubMed  CAS  Google Scholar 

  30. Borzy JC, Koch TK, Schimschock JR (2005) Effectiveness of topiramate in the treatment of pediatric chronic daily headache. Pediatr Neurol 33:314–316

    PubMed  Google Scholar 

  31. Bourgeois M, Aicardi J, Goutieres F (1993) Alternating hemiplegia of childhood. J Pediatr 122:673–679

    PubMed  CAS  Google Scholar 

  32. Bronfort G, Nilsson N, Haas M et al (2004) Non-invasive physical treatments for chronic/recurrent headache. Cochrane Database Syst Rev 3:CD001878

    PubMed  Google Scholar 

  33. Bruni O, Galli F, Guidetti V (1999) Sleep hygiene and migraine in children and adolescents. Cephalalgia 19 (Suppl 25):57–59

    PubMed  Google Scholar 

  34. Bussone G, Grazzi L, D’Amico D et al (1998) Biofeedback-assisted relaxation training for young adolescents with tension-type headache: a controlled study. Cephalalgia 18: 463–467

    PubMed  CAS  Google Scholar 

  35. Campistol J, Campos J, Casas C, Herranz JL (2005) Topiramate in the prophylactic treatment of migraine in children. J Child Neurol 20:251–253

    PubMed  Google Scholar 

  36. Caruso JM, Brown WD, Exil G, Gascon GG (2000) The efficacy of divalproex sodium in the prophylactic treatment of children with migraine. Headache 40:672–676

    PubMed  CAS  Google Scholar 

  37. Casaer P (1987) Flunarizine in alternating hemiplegia in childhood. An international study in 12 children. Neuropediatrics 18:191–195

    PubMed  CAS  Google Scholar 

  38. Childs AM, Meaney JF, Ferrie CD, Holland PC (2000) Neurovascular compression of the trigeminal and glossopharyngeal nerve: three case reports. Arch Dis Child 82:311–315

    PubMed  CAS  Google Scholar 

  39. Congdon PJ, Forsythe WI (1979) Migraine in childhood: a study of 300 children. Dev Med Child Neurol 21:209–216

    Google Scholar 

  40. Curless RG (1982) Cluster headaches in childhood. J Pediatrics 101:393–395

    CAS  Google Scholar 

  41. Damen L, Bruijn J, Koes BW et al (2006) Prophylactic treatment of migraine in children, part 1. A systematic review of non-pharmacological trials. Cephalalgia 26:373–383

    PubMed  CAS  Google Scholar 

  42. Damen L, Bruijn JKJ, Verhagen AP et al (2006) Prophylactic treatment of migraine in children, part 2. A systematic review of pharmacological trials. Cephalalgia 26:497–505

    PubMed  CAS  Google Scholar 

  43. D’Andrea G, Granella F (2001) SUNCT syndrome: the first case in childhood. Cephalalgia 21:701–702

    Google Scholar 

  44. De Almeida DB, Cunali PA, Santos HL et al (2004) Chronic paroxysmal hemicrania in early childhood: a case report. Cephalalgia 24:608–609

    Google Scholar 

  45. Denecke H, Kröner-Herwig B (2000) Kopfschmerz-Therapie mit Kindern und Jugendlichen. Ein Trainingsprogramm. Hogrefe, Göttingen

  46. Dignan F, Symon DNK, AbuArafeh I, Russell G (2001) The prognosis of cyclical vomiting syndrome. Arch Dis Child 84:55–57

    PubMed  CAS  Google Scholar 

  47. Dyb G, Holmen TL, Zwart JA (2006) Analgesic overuse among adolescents with headache: the Head-HUNT-Youth Study. Neurology 66:198–201

    PubMed  Google Scholar 

  48. Ebinger F (2003) Der kindliche Kopfschmerz. Besserung in der Pubertät oder ein Erwachsenenschicksal? Pädiatr Praxis 64:23–30

    Google Scholar 

  49. Ebinger F (2005) Kopfschmerzen bei Kindern und Jugendlichen – ein Update. Neuropädiatrie in Klinik Praxis 4:136–144

    Google Scholar 

  50. Eccleston C, Morley S, Williams A et al (2002) Systematic review of randomized controlled trials of psychological therapy for chronic pain in children and adolescents, with a subset meta-analysis of pain relief. Pain 99:157–165

    PubMed  Google Scholar 

  51. Egger J, Carter DM, Wilson J et al (1983) Is migraine food allergy? A double-blind controlled trial of oligoantigenic diet treatment. Lancet ii:865–869

    Google Scholar 

  52. Ekbom K (1999) Cluster headache: a clinical and pathophysiological review. In: Olesen J, Goadsby PJ (eds) Cluster headache and related conditions. Oxford University Press, Oxford, pp 13–22

  53. Ertekin V, Selimoglu MA, Altnkaynak S (2006) Prevalence of cyclic vomiting syndrome in a sample of Turkish school children in an urban area. J Clin Gastroenterol 40:896–898

    PubMed  Google Scholar 

  54. Evers S, Bauer B, Grotemeyer KH et al (1998) Event-related potentials (P300) in childhood and adolescence primary headache. J Child Neurol 13:322–326

    PubMed  CAS  Google Scholar 

  55. Evers S, Frese A, Majewski A et al (2002) Age of onset in cluster headache: the clinical spectrum. Cephalalgia 22:160–162

    PubMed  CAS  Google Scholar 

  56. Evers S, Frese A, May A et al (2005) Therapie seltener idiopathischer Kopfschmerzerkrankungen. Nervenheilkunde 24:217–226

    Google Scholar 

  57. Evers S, Rahmann A, Kraemer C et al (2006) Treatment of childhood migraine attacks with oral zolmitriptan and ibuprofen. Neurology 67:497–499

    PubMed  CAS  Google Scholar 

  58. Evers S (2007) Controlled trials in pediatric migraine: crossover versus parallel group. Curr Pain Headache Rep 11:241–244

    PubMed  Google Scholar 

  59. Fendrich K, Vennemann M, Pfaffenrath V et al (2007) Headache prevalence among adolescents – the German DMKG headache study. Cephalalgia 27:347–354

    PubMed  CAS  Google Scholar 

  60. Ferriere G (1985) Flunarizine in the prophylactic treatment of paediatric migraine. Cephalalgia 5 (Suppl 3):176–177

    Google Scholar 

  61. Fichtel A, Larsson B (2001) Does relaxation treatment have differential effects on migraine and tension-type headache in adolescents? Headache 41:290–296

    PubMed  CAS  Google Scholar 

  62. Fichtel, Larsson B (2004) Relaxation treatment administered by school nurses to adolescents with recurrent headache. Headache 44:545–554

    PubMed  Google Scholar 

  63. Fitzgerald DA (2007) Aspirin and Reye syndrome. Pediatr Drugs 9:205–206

    Google Scholar 

  64. Fitzpatrick E, Bourke B, Drumm B, Rowland M (2007) Outcome for children with cyclical vomiting syndrome. Arch Dis Child 92:1001–1004

    PubMed  CAS  Google Scholar 

  65. Forsythe WI, Gillies D, Sills MA (1984) Propranolol (Inderal) in the treatment of childhood migraine. Dev Med Child Neurol 26:737–741

    PubMed  CAS  Google Scholar 

  66. Fragoso YD, Machado PC (1998) Hemicrania continua with onset at an early age. Headache 38:792–793

    PubMed  CAS  Google Scholar 

  67. Frankenberg S (1999) Ernährungsverhaltensberatung bei Kopfschmerzen. Schmerz 13 (Suppl 1):38

    Google Scholar 

  68. Freedman SB, Fuchs S (2004) Antiemetic therapy in pediatric emergency departments. Pediatr Emerg Care 20:625–633

    PubMed  Google Scholar 

  69. Fusco C, Pisani F, Faienza C (2003) Idiopathic stabbing headache: clinical characteristics of children and adolescents. Brain Dev 25:237–240

    PubMed  Google Scholar 

  70. Gerber WD, Gerber-von-Müller G (2002) Verhaltensmedizinische Aspekte chronischer Kopfschmerzen im Kindes- und Jugendalter. Kindh Entwickl 11:140–151

    Google Scholar 

  71. Gillies D, Sills M, Forsythe I (1986) Pizotifen (Sandomigran) in childhood migraine. Eur Neurol 25:32–35

    PubMed  CAS  Google Scholar 

  72. Gladstein J, Holden EW, Peralta L (1994) Chronic paroxysmal hemicrania in a child. Headache 34:519–520

    PubMed  CAS  Google Scholar 

  73. Gokhale R, Huttenlocher PR, Brady L, Kirschner BS (1997) Use of barbiturate in the treatment of cyclic vomiting during childhood. J Pediatr Gastroenterol Nutr 25:64–67

    PubMed  CAS  Google Scholar 

  74. Goldstein M, Chen TC (1982) The epidemiology of disabling headache. Adv Neurol 33:377–390

    PubMed  CAS  Google Scholar 

  75. Gottschling S, Meyer S, Gribova I et al (2008) Laser acupuncture in children with headache: A double-blind, randomized, bicenter, placebo-controlled trial. Pain 137:405–412

    PubMed  Google Scholar 

  76. Grazzi L, Andrasik F, Usai S et al (2004) Pharmacological behavioural treatment for children and adolescents with tension-type headache. Neurol Sci 25:S270–S271

    PubMed  Google Scholar 

  77. Grazzi L, Andrasik F, Usai S, Bussone G (2005) Magnesium as a treatment for pediatric tension-type headache: a clinical replication series. Neurol Sci 25:338–341

    PubMed  CAS  Google Scholar 

  78. Grazzi L, Andrasik F, Usai S, Bussone G (2007) Magnesium as a preventive treatment for paediatric episodic tension-type headache: results at 1-year follow-up. Neurol Sci 28:148–150

    PubMed  CAS  Google Scholar 

  79. Guidetti V, Moscato D, Ottaviano S et al (1987) Flunarizine and migraine in childhood. An evaluation of endocrine function. Cephalalgia 7:263–266

    PubMed  CAS  Google Scholar 

  80. Haag G, Baar H, Grotemeyer KH et al (1999) Prophylaxe und Therapie des medikamenteninduzierten Dauerkopfschmerzes. Therapieempfehlungen der Deutschen Migräne- und Kopfschmerzgesellschaft. Nervenheilkunde 18:143–146

    Google Scholar 

  81. Haghighat M, Rafie SM, Dehghani SM et al (2007) Cyclic vomiting syndrome in children: experience with 181 cases from southern Iran. World J Gastroenterol 13:1833–1836

    PubMed  Google Scholar 

  82. Hämäläinen ML, Hoppu K, Valkeila E, Santavuori P (1997) Ibuprofen or acetaminophen for the acute treatment of migraine in children. Neurology 48:103–107

    PubMed  Google Scholar 

  83. Hämäläinen ML, Hoppu K, Santavuori P (1997) Sumatriptan for migraine attacks in children: a randomized, placebo-controlled study. Neurology 48:1100–1103

    PubMed  Google Scholar 

  84. Hämäläinen ML, Hoppu K, Santavuori P (1997) Oral dihydroergotamine for therapy-resistant migraine attacks in children. Pediatr Neurol 16:114–117

    PubMed  Google Scholar 

  85. Harel Z, Cascon G, Riggs S et al (2002) Supplementation with omega-3 polyunsaturated fatty acids in the management of recurrent migraines in adolescents. J Adolesc Health 31:154–161

    PubMed  Google Scholar 

  86. Headache Classification Committee of the International Headache Society (2004) The international classification of headache disorders, 2nd edition. Cephalalgia 24 (Suppl 1):1–160

    Google Scholar 

  87. Hering-Hanit R, Gadoth N, Cohen A, Horev Z (2001) Successful withdrawal from analgesic abuse in a group of youngsters with chronic daily headache. J Child Neurol 16:448–449

    PubMed  CAS  Google Scholar 

  88. Hering-Hanit R, Gadoth N (2003) Caffeine-induced headache in children and adolescents. Cephalalgia 23:332–335

    PubMed  CAS  Google Scholar 

  89. Hermann C, Kim M, Blanchard EB (1995) Behavioral and prophylactic pharmacological intervention studies of pediatric migraine: an exploratory meta-analysis. Pain 60:239–256

    PubMed  CAS  Google Scholar 

  90. Hershey AD, Powers SW, Bentti AL, deGrauw TJ (2000) Effectiveness of amitriptyline in the prophylactic management of childhood headaches. Headache 40:539–549

    PubMed  CAS  Google Scholar 

  91. Hershey AD, Powers SW, LeCates S, Bentti AL (2001) Effectiveness of nasal Sumatriptan in 5- to 12-year-old children. Headache 41:693–697

    PubMed  CAS  Google Scholar 

  92. Hershey AD, Powers SW, Vockell ALB (2002) Effectiveness of topiramate in the prevention of childhood headaches. Headache 42:810–818

    PubMed  Google Scholar 

  93. Hershey AD, Powers SW, Vockell ALB (2007) Coenzyme Q10 deficiency and response to supplementation in pediatric and adolescent migraine. Headache 47:73–80

    PubMed  Google Scholar 

  94. Jiang W, Chi Z, Ma L et al (2006) Topiramate: a new agent for patients with alternating hemiplegia of childhood. Neuropediatrics 37:229–233

    PubMed  CAS  Google Scholar 

  95. Kandt RS, Daniel FL (1986) Glossopharyngeal neuralgia in a child. A diagnostic and therapeutic dilemma. Arch Neurol 43:301–302

    PubMed  CAS  Google Scholar 

  96. Karch D, Boltshauser E, Groß-Selbeck G et al (2005) Manualmedizinische Behandlung des KISS-Syndroms und der Atlastherapie nach Arlen. Stellungnahme der Gesellschaft für Neuropädiatrie e.V.: Kommission zu Behandlungsverfahren bei Entwicklungsstörungen und zerebralen Bewegungsstörungen. Manuelle Med 43:100–105

    Google Scholar 

  97. Klassen BD, Dooley JM (2000) Chronic paroxysmal hemicrania-like headache in a child: response to a headache diary. Headache 40:853–855

    PubMed  CAS  Google Scholar 

  98. Korsgard AG (1995) The tolerability, safety and efficacy of oral sumatriptan 50 mg and 100 mg for the acute treatment of migraine in adolescents [abstract]. Cephalalgia 15 (Suppl 16):99

    Google Scholar 

  99. Kossoff EH, Mankad DN (2006) Medication-overuse headache in children: is initial preventive therapy necessary? J Child Neurol 21:45–48

    PubMed  Google Scholar 

  100. Kothare SV (2005) Efficacy of flunarizine in the prophylaxis of cyclical vomiting syndrome and abdominal migraine. Eur J Paediatr Neurol 9:23–26

    PubMed  Google Scholar 

  101. Kovac AL (2007) Management of postoperative nausea and vomiting in children. Paediatr Drugs 9 47–69

    Google Scholar 

  102. Kröner-Herwig B, Mohn U, Pothmann R (1998) Comparison of biofeedback and relaxation in the treatment of pediatric headache and the influence of parent involvement on outcome. Appl Psychophysiol Biofeedback 23:143–157

    PubMed  Google Scholar 

  103. Kröner-Herwig B, Heinrich M, Morris L (2007) Headache in German children and adolescents: a population-based epidemiological study. Cephalalgia 27:519–527

    PubMed  Google Scholar 

  104. Kruse M, Ebinger F (2007) Alternierende Hemiplegie im Kindesalter – ein Update. Neuropädiatrie in Klinik und Praxis 6:64–69

    Google Scholar 

  105. Krymchantowski AV, Nobre ME, Moreira P (2000) Low-dose flunarizine for the prevention of migraine in children. Headache 11:119–121

    Google Scholar 

  106. Kudrow L (1980) Cluster headache: mMechanism and management. Oxford University Press, Oxford

  107. Kudrow DB, Kudrow L (1989) Successful aspirin prophylaxis in a child with chronic paroxysmal hemicrania. Headache 29:280–281

    PubMed  CAS  Google Scholar 

  108. Lakshmi CV, Singhi P, Malhi P, Ray M (2007) Topiramate in the prophylaxis of pediatric migraine: A double-blind placebo-controlled trial. J Child Neurol 22:829–835

    PubMed  CAS  Google Scholar 

  109. Lampl C (2002) Childhood-onset cluster headache. Pediatr Neurol 27:138–140

    PubMed  Google Scholar 

  110. Larsson B, Carlsson J, Fichtel A, Melin L (2005) Relaxation treatment of adolescent headache sufferers: Results from a school-based replication series. Headache 45:692–704

    PubMed  Google Scholar 

  111. Lee LH, Olness KN (1997) Clinical and demographic characteristics of migraine in urban children. Headache 37:269–276

    PubMed  CAS  Google Scholar 

  112. Leung AK, Robson WL (2007) Acute gastroenteritis in children: role of anti-emetic medication for gastroenteritis-related vomiting. Paediatr Drugs 9:175–184

    PubMed  Google Scholar 

  113. Lewis DW, Kellstein D, Dahl G et al (2002) Children’s ibuprofen suspension for the acute treatment of pediatric migraine headache. Headache 42:780–786

    PubMed  Google Scholar 

  114. Lewis D, Ashwal S, Hershey A et al (2004) Practice parameter: pharmacological treatment of migraine headache in children and adolescents. Report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology 63:2215–2224

    PubMed  CAS  Google Scholar 

  115. Lewis D, Diamond S, Scott D, Jones V (2004) Prophylactic treatment of pediatric migraine. Headache 44:230–237

    PubMed  Google Scholar 

  116. Lewis DW, Gozzo YF, Avner MT (2005) The other primary headaches in children and adolescents. Pediatr Neurol 33:303–313

    PubMed  Google Scholar 

  117. Lewis DW, Paradiso E (2007) A double-blind, dose comparison study of topiramate for prophylaxis of basilar-type migraine in children: a pilot study. Headache 47:1409–1417

    PubMed  Google Scholar 

  118. Lewis DW, Winner P, Hershey AF, Wasiewski WW (2007) Adolescent Migraine Steering Committee. Efficacy of zolmitriptan nasal spray in adolescent migraine. Pediatrics 120:390–396

    PubMed  Google Scholar 

  119. Li BU, Murray RD, Heitlinger LA et al (1999) Is cyclic vomiting syndrome related to migraine? J Pediatr 134:567–572

    PubMed  CAS  Google Scholar 

  120. Linder SL (1994) Treatment of childhood headache with dihydroergotamine mesylate. Headache 34:578–580

    PubMed  CAS  Google Scholar 

  121. Linder SL (1996) Subcutaneous sumatriptan in the clinical setting: the first 50 consecutive patients with acute migraine in a pediatric neurology office practice. Headache 36:419–422

    PubMed  CAS  Google Scholar 

  122. Linder SL, Mathew NT, Cady RK et al (2006) A randomized, double-blind, placebo-controlled study of oral almotriptan 6.25 mg, 12.5 mg, and 25 mg in the acute treatment of migraine in adolescents. Ann Neurol 60:S152

    Google Scholar 

  123. Longo G, Rudoi I, Iannuccelli M et al (1984) Treatment of essential headache in developmental age with L-5-HTP (crossover double-blind study versus placebo). Pediatr Med Chir 6:241–245

    PubMed  CAS  Google Scholar 

  124. Lopes PG, Castro ES Jr, Lopes LH (2002) Trigeminal neuralgia in children: two case reports. Pediatr Neurol 26:309–310

    PubMed  Google Scholar 

  125. Ludvigsson J (1974) Propranolol used in prophylaxis of migraine in children. Acta Neurol Scand 50:109–115

    Article  PubMed  CAS  Google Scholar 

  126. Luka-Krausgrill U (1998) Kognitive Verhaltenstherapie bei Kopfschmerzen im Kindes- und Jugendalter. In: Hautzinger M (Hrsg) Kognitive Verhaltenstherapie bei psychischen Störungen. Beltz, Weinheim, S 477–516

  127. Lütschg J, Vassella F (1990) Behandlung der kindlichen Migräne mit Flunarizin bzw. Propranolol. Schweiz Med Wochenschr 120:1731–1736

    PubMed  Google Scholar 

  128. MacDonald JT (1994) Treatment of juvenile migraine with subcutaneous sumatriptan. Headache 34:581–582

    PubMed  CAS  Google Scholar 

  129. Mack KJ (2004) What incites new daily persistent headache in children? Pediatr Neurol 31:122–125

    PubMed  Google Scholar 

  130. Marshall PC, Rosman NP (1977) Symptomatic trigeminal neuralgia in a 5-year-old child. Pediatrics 60:331–333

    PubMed  CAS  Google Scholar 

  131. Mason WE, Kollros P, Jannetta PJ (1991) Trigeminal neuralgia and its treatment in a 13-month-old child: a review and case report. J Craniomandib Disord 5:213–216

    PubMed  CAS  Google Scholar 

  132. Mauskop A, Farkkila M, Hering-Hanit R et al (1999) Zolmitriptan is effective for the treatment of persistent and recurrent migraine headache. Curr Med Res Opin 15:282–289

    PubMed  CAS  Google Scholar 

  133. May A, Evers S, Straube A et al (2004) Therapie und Prophylaxe von Clusterkopfschmerzen und anderen trigemino-autonomen Kopfschmerzen. Nervenheilkunde 23:478–490

    Google Scholar 

  134. Maytal J, Lipton RB, Solomon S, Shinnar S (1992) Childhood onset cluster headache. Headache 32:275–279

    PubMed  CAS  Google Scholar 

  135. Maytal J, Young M, Shechter A, Lipton RB (1997) Pediatric migraine and the International Headache Society (IHS) criteria. Neurology 48:602–607

    PubMed  CAS  Google Scholar 

  136. McNabb S, Whitehouse W (1999) Cluster headache-like disorder in childhood. Arch Dis Child 81:511–512

    PubMed  CAS  Google Scholar 

  137. Melchart D, Linde K, Fischer P et al (1999) Acupuncture for recurrent headaches: a systematic review of randomized controlled trials. Cephalalgia 19:779–786

    PubMed  CAS  Google Scholar 

  138. Metsähonkala L, Sillanpää M, Tuominen J (1998) Social Environment and headache on 8- to 9-year-old children: a follow-up study. Headache 38:222–228

    PubMed  Google Scholar 

  139. Miller GS (2004) Efficacy and safety of levetiracetamin pediatric migraine. Headache 44:238–243

    PubMed  Google Scholar 

  140. Millichap JG, Yee MM (2003) The diet factor in pediatric and adolescent migraine. Pediatr Neurol 28:9–15

    PubMed  Google Scholar 

  141. Monastero R, Camarda R, Pipia C, Camarda R (2006) Prognosis of migraine headache in adolescents: a 10-year follow-up study. Neurology 76:1353–1356

    Google Scholar 

  142. Mortimer MJ, Kay J, Jaron A (1992) Epidemiology of headache and childhood migraine in an urban general practice using Ad hoc, Vahlquist and IHS criteria. Dev Med Child Neurol 34:516–523

    Google Scholar 

  143. Mortimer MJ, Kay J, Jaron A (1993) Clinical epidemiology of childhood abdominal migraine in an urban general practice. Dev Med Child Neurol 35:243–248

    Article  PubMed  CAS  Google Scholar 

  144. Noronha MJ (1985) Double blind randomised cross-over trial of timolol in migraine prophylaxis of children. Cephalalgia 5 (Suppl 3):174–175

    Google Scholar 

  145. Oelkers-Ax R, Leins A, Parzer P et al (2008) Butterbur root extract and music therapy in the prevention of childhood migraine: an explorative study. Europ J Pain 12:301–313

    Google Scholar 

  146. Olness K, MacDonald JT, Uden DL (1987) Comparison of self-hypnosis and propranolol in the treatment of juvenile classic migraine. Pediatrics 79:593–597

    PubMed  CAS  Google Scholar 

  147. Pakalnis A, Greenberg G, Drake ME, Paolichi J (2001) Pediatric migraine prophylaxis with divalproex. J ChildNeurol 16:731–734

    CAS  Google Scholar 

  148. Pakalnis A, Kring D (2006) Zonisamide prophylaxis in refractory pediatric headache. Headache 46:804–807

    PubMed  Google Scholar 

  149. Pakalnis A, Kring D, Meier L (2007) Levetiracetam prophylaxis in pediatric migraine – an open-label study. Headache 47:427–430

    PubMed  Google Scholar 

  150. Pascual J, Berciano J (1995) Clinical experience with headaches in preadolescent children. Headache 35:551–553

    PubMed  CAS  Google Scholar 

  151. Pfefferbaum B, Hagberg CA (1993) Pharmacological management of pain in children. J Am Acad Child Adolesc Psychiatry 32:235–242

    Article  PubMed  CAS  Google Scholar 

  152. Pintov S, Lahat E, Alstein M et al (1997) Acupuncture and the opioid system: implications in management of migraine. Pediatr Neurol 17:129–133

    PubMed  CAS  Google Scholar 

  153. Pothmann R (1987) Calcium-antagonist flunarizine vs. low-dose acetylsalicylic acid in childhood migraine; a double-blind study. Cephalalgia 7 (Suppl 6):385–386

    Google Scholar 

  154. Pothmann R (1990) Transkutane elektrische Nervenstimulation zur Schmerztherapie. Kinderarzt 21:706–712

    Google Scholar 

  155. Pothmann R (1994) Migräne bei Kindern. In: Ensink FBM, Soyka D (Hrsg) Migräne. Aktuelle Aspekte eines altbekannten Leidens. Springer, Berlin Heidelberg New York, S 477–500

  156. Pothmann R (1999) Kopfschmerzen im Kindesalter. Hippokrates, Stuttgart

  157. Pothmann R, Winter K (1989) Migraine prophylaxis with DHE: a double blind placebo-controlled study. Cephalalgia 9 (Suppl 10):427–428

    Google Scholar 

  158. Pothmann R, Plump U, Maibach G et al (1991) Migränetagebuch für Kinder. Arcis, München

  159. Pothmann R, Lobisch M (2000) Akutbehandlung des episodischen kindlichen Spannungskopfschmerzes mit Flupirtin und Paracetamol. Schmerz 14:1–4

    PubMed  CAS  Google Scholar 

  160. Pothmann R, Danesch U (2005) Migraine prevention in children and adolescents: Results of an open study with a special butterbur root extract. Headache 45:196–203

    PubMed  Google Scholar 

  161. Pothmann R, Frankenberg S, Lüdtke R et al (2005) Ernährungsmedizinische Therapie bei Kindern mit Kopfschmerzen – ein randomisierter Vergleich. Neuropädiatrie in Klinik und Praxis 4:86–91

    Google Scholar 

  162. Powers SW, Mitchell MJ, Byars KC et al (2001) A pilot study of one-session biofeedback training in pediatric headache. Neurology 56:133

    PubMed  CAS  Google Scholar 

  163. Raieli V, Eliseo G, Manfrè L et al (2001) Trigeminal neuralgia and cerebellopontine-angle lipoma in a child. Headache 41:720–722

    PubMed  CAS  Google Scholar 

  164. Ramanathan M, Parameshwaran AA, Jayakumar N, Raghaviah AM (2007) Reactivation of trigeminal neuralgia following distraction osteogenesis in an 8-year-old child: report of a unique case. J Indian Soc Pedod Prev Dent 25:49–51

    PubMed  CAS  Google Scholar 

  165. Reiter PD, Nickisch J, Merritt G (2005) Efficacy and tolerability of intravenous valproic acid in acute adolescent migraine. Headache 45:899–903

    PubMed  Google Scholar 

  166. Resnick DK, Levy EI, Jannetta PJ (1998) Microvascular decompression for pediatric onset trigeminal neuralgia. Neurosurgery 43:804–807

    PubMed  CAS  Google Scholar 

  167. Roski RA, Horwitz SJ, Spetzler RF (1982) Atypical trigeminal neuralgia in a 6-year-old boy. Case report. J Neurosurg 56:424–425

    PubMed  CAS  Google Scholar 

  168. Rothner A, Edwards K, Kerr L et al (1997) Efficacy and safety of naratriptan tablets in adolescent migraine. J Neurol Sci 150:106

    Google Scholar 

  169. Rothner AD, Wasiewski W, Winner P et al (2006) Zolmitriptan oral tablet in migraine treatment: high placebo responses in adolescents. Headache 46:101–109

    PubMed  Google Scholar 

  170. Russell G, Abu-Arafeh I (1999) Paroxysmal vertigo in children - an epidemiological study. Int J Pediatr Otorhinolaryngol 49 (Suppl 1):S105–S107

    PubMed  Google Scholar 

  171. Salfield SAW, Wardley BL, Houlsby WT et al (1987) Controlled study of exclusion of dietary vasoactive amines in migraine. Arch Dis Child 62:458–460

    PubMed  CAS  Google Scholar 

  172. Salmon MA, Walters DD (1985) Pizotifen in the prophylaxis of cyclical vomiting. Lancet i:1036–1037

    Google Scholar 

  173. Santucci M, Cortelli P, Rossi PG et al (1986) L-5-Hydroxytryptophan versus placebo in childhood migraine prophylaxis: a double-blind crossover study. Cephalalgia 6:155–157

    PubMed  CAS  Google Scholar 

  174. Sasaki M, Sakuragawa N, Osawa M (2001) Longterm effect of flunarizine on patients with alternating hemiplegia of childhood in Japan. Brain Dev 23:303–305

    PubMed  CAS  Google Scholar 

  175. Schlarb AA, Hautzinger M (2007) Nichtmedikamentöse Therapie bei Kindern mit Migräne oder Spannungskopfschmerz. Kinder- und Jugendarzt 38:435–439

  176. Schrör K (2007) Aspirin and Reye syndrome: a review of evidence. Paediatr Drugs 9:195–204

    PubMed  Google Scholar 

  177. Seemann H, Franck G, Ochs M et al (2002) Chronifizierungsprävention primärer Kopfschmerzen bei Kindern und Jugendlichen. Kindh Entwickl 211:185–197

    Google Scholar 

  178. Sekhara T, Pelc K, Mewasingh LD et al (2005) Pediatric SUNCT syndrome. Pediatr Neurol 33:206–207

    PubMed  Google Scholar 

  179. Serdaroglu G, Erhan E, Tekgul H et al (2002) Sodium valproate prophylaxis in childhood migraine. Headache 42:819–822

    PubMed  Google Scholar 

  180. Shabbir N, McAbee G (1994) Adolescent chronic paroxysmal hemicrania responsive to verapamil monotherapy. Headache 34:209–210

    PubMed  CAS  Google Scholar 

  181. Sillanpää M (1977) Clonidine prophylaxis of childhood migraine and other vascular headaches. Headache 17:28–31

    PubMed  Google Scholar 

  182. Sillanpää M, Koponen M (1978) Papaverine in the prophylaxis of migraine and other vascular headaches in children. Acta Paediatr Scand 67:209–212

    PubMed  Google Scholar 

  183. Sillanpää M (1983) Changes in the prevalence of migraine and other headache during the first seven school years. Headache 23:15–19

    PubMed  Google Scholar 

  184. Sillanpää M, Piekkala P, Kero P (1991) Prevalence of headache at preschool age in an unselected child population. Cephalalgia 11:239–242

    PubMed  Google Scholar 

  185. Sillanpää M, Anttila P (1996) Increasing prevalence of headache in 7-year-old schoolchildren. Headache 36:466–470

    PubMed  Google Scholar 

  186. Sills M, Congdon P, Forsythe I (1982) Clonidine and childhood migraine: a pilot and double-blind study. Dev Med Child Neurol 24:837–841

    Article  PubMed  CAS  Google Scholar 

  187. Silver K, Andermann F (1993) Alternating hemiplegia of childhood: a study of 10 patients and results of flunarizine treatment. Neurology 43:36–41

    PubMed  CAS  Google Scholar 

  188. Siniatchkin M, Hierundar A, Kropp P et al (2000) Self-regulation of slow cortical potentials in children with migraine: an exploratory study. Appl Psychophysiol Biofeedback 25:13–32

    PubMed  CAS  Google Scholar 

  189. Solomon S, Newman LC (1995) Chronic paroxysmal hemicrania in a child? Headache 35:234–235

    PubMed  CAS  Google Scholar 

  190. Solomon GD, Cady RK, Klapper JA et al (1997) Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine. The 042 Clinical Trial Study Group. Neurology 49:1219–1225

    PubMed  CAS  Google Scholar 

  191. Solth A, Veelken N, Gottschalk J et al (2008) Successful vascular decompression in an 11-year-old patient with trigeminal neuralgia. Childs Nerv Syst 24:763–766

    PubMed  CAS  Google Scholar 

  192. Sorge F, Barone P, Steardo L, Romano MR (1982) Amitriptyline as a prophylactic for migraine in children. Acta Neurol (Napoli) 4:362–367

    Google Scholar 

  193. Sorge F, Marano E (1985) Flunarizine v. placebo in childhood migraine: a double-blind study. Cephalalgia 5 (Suppl 2):145–148

    PubMed  Google Scholar 

  194. Sorge F, de Simone R, Marano E et al (1988) Flunarizine in prophylaxis of childhood migraine: a double-blind, placebo-controlled, cross over study. Cephalalgia 8:1–6

    PubMed  CAS  Google Scholar 

  195. Soriani S, Battistella PA, Arnaldi C et al (1996) Juvenile idiopathic stabbing headache. Headache 36:565–567

    PubMed  CAS  Google Scholar 

  196. Symon DN, Russell G (1995) Double blind placebo controlled trial of pizotifen syrup on the treatment of abdominal migraine. Arch Dis Child 72:48–50

    PubMed  CAS  Google Scholar 

  197. Symon DNK (1998) Twelve cases of analgesic headache. Arch Dis Child 78:555–556

    PubMed  CAS  Google Scholar 

  198. Talvik I, Koch K, Kolk A, Talvik T (2006) Chronic paroxysmal hemicrania in a 3-year, 10-month-old female. Pediatr Neurol 34:225–227

    PubMed  Google Scholar 

  199. Tan V, Sahami AR, Peebles R, Shaw RJ (2006) Abdominal migraine and treatment with intravenous valproic acid. Psychosomatics 47:353–355

    PubMed  Google Scholar 

  200. Tepper SJ, Donnan GA, Dowson AJ et al (1999) A long-term study to maximise migraine relief with zolmitriptan. Curr Med Res Opin 15:254–271

    Article  PubMed  CAS  Google Scholar 

  201. Tonini M, Cipollina L, Poluzzi E et al (2004) Clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics. Aliment Pharmacol Ther 19:379–390

    PubMed  CAS  Google Scholar 

  202. Trautmann E, Lackschewitz H, Kröner-Herwig B (2006) Psychological treatment of recurrent headache in children and adolescents – a meta-analysis. Cephalalgia 26:1411–1426

    PubMed  CAS  Google Scholar 

  203. Überall M, Wenzel D (1999) Intranasal sumatriptan for the acute treatment of migraine in children. Neurology 52:1507–1510

    Google Scholar 

  204. Van Calcar SC, Harding CO, Wolff JA (2002) L-carnitine administration reduces number of episodes in cyclic vomiting syndrome. Clin Pediatr 41:171–174

    Google Scholar 

  205. Vanderhoof JA, Young R, Kaufman SS, Ernst L (1993) Treatment of cyclic vomiting in childhood with erythromycin. J Pediatr Gastroenterol Nutr 17:387–391

    Article  PubMed  CAS  Google Scholar 

  206. Vanderhoof JA, Young R, Kaufman SS, Ernst L (1995) Treatment of cyclic vomiting in childhood with erythromycin. J Pediatr Gastroenterol Nutr 21 (Suppl 1):S60–S62

    PubMed  Google Scholar 

  207. Vasconcellos E, Pina-Garza JE, Millan EJ, Warner JS (1998) Analgesic rebound headache in children and adolescents. J Child Neurol 13:443–447

    PubMed  CAS  Google Scholar 

  208. Victor S, Ryan SW (2003) Drugs for preventing migraine headaches in children. Cochrane Database Syst Rev 4:CD002761

    PubMed  Google Scholar 

  209. Vieira JP, Salgueiro AB, Alfaro M (2006) Short-lasting headaches in children. Cephalalgia 26:1220–1224

    PubMed  CAS  Google Scholar 

  210. Visser WH, Winner P, Strohmaier K et al (2004) Rizatriptan protocol 059 and 061 study groups. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies. Headache 44:891–899

    PubMed  Google Scholar 

  211. Visudtibhan A, Lusawat A, Chiemchanya S, Visudhiphan P (2004) Flunarizine for prophylactic treatment of childhood migraine. J Med Assoc Thai 87:1466–1470

    PubMed  Google Scholar 

  212. Volcy M, Tepper SJ, Rapoport AM et al (2005) Short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms (SUNA)- a case report. Cephalalgia 25:470–472

    PubMed  CAS  Google Scholar 

  213. Wang F, van den Eeden SK, Ackerson LM et al (2003) Oral magnesium oxide prophylaxis of frequent migrainous headache in children: a randomized, double-blind, placebo-controlled trial. Headache 43:601–610

    PubMed  Google Scholar 

  214. Winner P, Rothner AD, Saper J et al (2000) A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents. Pediatrics 106:989–997

    PubMed  CAS  Google Scholar 

  215. Winner P, Lewis D, Visser WH et al (2002) Rizatriptan Adolescence Study Group. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled study. Headache 42:49

    PubMed  Google Scholar 

  216. Winner P, Pearlman EM, Linder SL et al (2005) Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial. Headache 45:1304–1312

    PubMed  Google Scholar 

  217. Winner P, Gendolla A, stayer C et al (2006) Topiramate for migraine prevention in adolescents: a pooled analysis of efficacy and safety. Headache 46:1503–1510

    PubMed  Google Scholar 

  218. Winner P, Rothner D, Wooten J et al (2006) Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study. Headache 46:212–222

    PubMed  Google Scholar 

  219. Winner P, Linder S, Lipton RB et al (2007) Eletriptan for the acute treatment of migraine in adolescents: results of a double-blind, placebo-controlled trial. Headache 47:511–518

    PubMed  Google Scholar 

  220. Worawattanakul M, Rhoads JM, Lichtman SN, Ulshen MH (1999) Abdominal migraine: prophylactic treatment and follow-up. J Pediatr Gastroenterol Nutr 28:37–40

    PubMed  CAS  Google Scholar 

  221. Yglesias A, Narbona J, Vanaclocha V, Artieda J (1996) Chiari type I malformation, glossopharyngeal neuralgia and central sleep apnoea in a child. Dev Med Child Neurol 38:1126–1130

    Article  PubMed  CAS  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to F. Ebinger.

Additional information

Evers S, Pothmann R, Überall M et al. (2001) Therapie idiopathischer Kopfschmerzen im Kindesalter. Nervenheilkunde 20: 306–315 und (2002) Schmerz 16: 48–56.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ebinger, F., Kropp, P., Pothmann, R. et al. Therapie idiopathischer Kopfschmerzen im Kindes- und Jugendalter. Monatsschr Kinderheilkd 157, 599–610 (2009). https://doi.org/10.1007/s00112-009-2002-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00112-009-2002-1

Schlüsselwörter

Keywords

Navigation